Literature DB >> 9353022

Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization.

J Hill1, S E Leary, K F Griffin, E D Williamson, R W Titball.   

Abstract

V antigen of Yersinia pestis is a multifunctional protein that has been implicated as a protective antigen, a virulence factor, and a regulatory protein. A series of V-antigen truncates expressed as glutathione S-transferase (GST) fusion proteins (GST-V truncates) have been cloned and purified to support immunogenicity and functionality studies of V antigen. Immunization studies with GST-V truncates have identified two regions of V antigen that confer protection against Y. pestis 9B (a fully virulent human pneumonic plague isolate) in a mouse model for plague. A minor protective region is located from amino acids 2 to 135 (region I), and a major protective region is found between amino acids 135 and 275 (region II). In addition, analysis of IgG titers following immunization suggested that the major antigenic region of V antigen is located between amino acids 135 and 245. A panel of monoclonal antibodies raised against recombinant V antigen was characterized by Western blotting against GST-V truncates, and epitopes of most of the monoclonal antibodies were mapped to region I or II. Monoclonal antibody 7.3, which recognizes an epitope in region II, passively protected mice against challenge with 12 median lethal doses of Y. pestis GB, indicating that region II encodes a protective epitope. This is the first report of a V-antigen-specific monoclonal antibody that will protect mice against a fully virulent strain of Y. pestis. The combined approach of passive and active immunization has therefore confirmed the importance of the central region of the protein for protection and also identified a previously unknown protective region at the N terminus of V antigen.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353022      PMCID: PMC175643          DOI: 10.1128/iai.65.11.4476-4482.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Plague immunization. II. Relation of adverse clinical reactions to multiple immunizations with killed vaccine.

Authors:  J D Marshall; P J Bartelloni; D C Cavanaugh; P J Kadull; K F Meyer
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

Review 2.  Plague immunization. I. Past and present trends.

Authors:  K F Meyer; D C Cavanaugh; P J Bartelloni; J D Marshall
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

3.  Plague immunization. V. Indirect evidence for the efficacy of plague vaccine.

Authors:  D C Cavanaugh; B L Elisberg; C H Llewellyn; J D Marshall; J H Rust; J E Williams; K F Meyer
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

4.  Molecular analysis of lcrGVH, the V antigen operon of Yersinia pestis.

Authors:  S B Price; K Y Leung; S S Barve; S C Straley
Journal:  J Bacteriol       Date:  1989-10       Impact factor: 3.490

5.  Analysis of the V antigen lcrGVH-yopBD operon of Yersinia pseudotuberculosis: evidence for a regulatory role of LcrH and LcrV.

Authors:  T Bergman; S Håkansson; A Forsberg; L Norlander; A Macellaro; A Bäckman; I Bölin; H Wolf-Watz
Journal:  J Bacteriol       Date:  1991-03       Impact factor: 3.490

6.  Roles of V antigen in promoting virulence and immunity in yersiniae.

Authors:  T Une; R R Brubaker
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

7.  The Yersinia pestis V antigen is a regulatory protein necessary for Ca2(+)-dependent growth and maximal expression of low-Ca2+ response virulence genes.

Authors:  S B Price; C Cowan; R D Perry; S C Straley
Journal:  J Bacteriol       Date:  1991-04       Impact factor: 3.490

8.  Effectiveness of live or killed plague vaccines in man.

Authors:  K F Meyer
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

9.  Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague.

Authors:  S E Leary; E D Williamson; K F Griffin; P Russell; S M Eley; R W Titball
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

10.  Differential regulation of IgG1 and IgE synthesis by interleukin 4.

Authors:  C M Snapper; F D Finkelman; W E Paul
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

View more
  55 in total

1.  Probing molecular interactions in intact antibody: antigen complexes, an electrospray time-of-flight mass spectrometry approach.

Authors:  M A Tito; J Miller; N Walker; K F Griffin; E D Williamson; D Despeyroux-Hill; R W Titball; C V Robinson
Journal:  Biophys J       Date:  2001-12       Impact factor: 4.033

2.  Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis.

Authors:  Jim Hill; Catherine Copse; Sophie Leary; Anthony J Stagg; E Diane Williamson; Richard W Titball
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

3.  Protein binding between PcrG-PcrV and PcrH-PopB/PopD encoded by the pcrGVH-popBD operon of the Pseudomonas aeruginosa type III secretion system.

Authors:  Leonard R Allmond; Timur J Karaca; Vinh N Nguyen; Thong Nguyen; Jeanine P Wiener-Kronish; Teiji Sawa
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 4.  Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.

Authors:  David G Thanassi; James B Bliska; Peter J Christie
Journal:  FEMS Microbiol Rev       Date:  2012-05-24       Impact factor: 16.408

5.  Purification and characterization of Yersinia enterocolitica and Yersinia pestis LcrV-cholera toxin A(2)/B chimeras.

Authors:  Juliette K Tinker; Chadwick T Davis; Britni M Arlian
Journal:  Protein Expr Purif       Date:  2010-05-11       Impact factor: 1.650

6.  Administration of antibody to the lung protects mice against pneumonic plague.

Authors:  Jim Hill; Jim E Eyles; Stephen J Elvin; Gareth D Healey; Roman A Lukaszewski; Richard W Titball
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

7.  Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis.

Authors:  Ho-Ki Shim; Julie A Musson; Helen M Harper; Hesta V McNeill; Nicola Walker; Helen Flick-Smith; Alexei von Delwig; E Diane Williamson; John H Robinson
Journal:  Immunology       Date:  2006-08-18       Impact factor: 7.397

8.  Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge.

Authors:  Christine G Branger; Wei Sun; Ascención Torres-Escobar; Robert Perry; Kenneth L Roland; Jacqueline Fetherston; Roy Curtiss
Journal:  Vaccine       Date:  2010-10-24       Impact factor: 3.641

9.  Amino acid residues 196-225 of LcrV represent a plague protective epitope.

Authors:  Lauriane E Quenee; Bryan J Berube; Joshua Segal; Derek Elli; Nancy A Ciletti; Deborah Anderson; Olaf Schneewind
Journal:  Vaccine       Date:  2009-12-10       Impact factor: 3.641

10.  Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

Authors:  A Nowakowski; C Wang; D B Powers; P Amersdorfer; T J Smith; V A Montgomery; R Sheridan; R Blake; L A Smith; J D Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.